Stock Price
0.46
Daily Change
-0.03 -5.15%
Monthly
35.29%
Yearly
300.00%
Q1 Forecast
0.49

Starpharma Holdings reported AUD-1.03M in EBIT for its fiscal semester ending in December of 2023.





Ebit Change Date
Medical Developments International AUD -12.12M 3.97M Jun/2023
Mesoblast USD -42.11M 21.69M Jun/2025
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024